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Abstract
Background Rat gastroduodenal reflux models have been used for analyzing Barrett’s carcinogenesis. Mice seem to be more 
useful than rats for studies targeting genes.
Methods We induced gastroduodenal contents reflux by esophagojejunostomy using C57BL/6J mice. Mice were divided into 
a standard diet and high-fat diet groups and kept for 60 weeks. Bile was sampled from the gallbladder to analyze bile acid 
fractions, and the esophagus was removed for a histological investigation. Human esophagogastric junction adenocarcinoma 
cells (OE19) were exposed to taurocholic acid (TCA), after which cell proliferative activity was measured. Rat esophageal 
cancer cell lines, ESCC-DR and ESCC-DRtca with higher malignant potential induced by continuous TCA exposure, were 
used to perform comprehensive genetic analysis (CGH).
Results Barrett’s epithelium onset occurred in all mice, and no differences in histological changes were noted between the 
standard diet and high-fat diet groups. However, no development of adenocarcinoma was noted. Most of the mouse bile acid 
was taurine conjugates. In the experiment using OE-19 cells, TCA promotes cell proliferation in a dose-dependent manner. 
Array CGH analysis revealed a large number of chromosomal abnormalities in the ESCC-DR, in addition to genetic abnor-
malities such as in the UGT2B gene, the substrate of which is bile acid. TCA administration resulted in more chromosomal 
abnormalities being detected.
Conclusions We showed the effects of TCA in cancer progression in vitro. However, Barrett’s adenocarcinoma onset rates 
differ between mice and rats despite undergoing similar reflux stimulation including taurine-conjugated bile acids being 
detected in mouse bile juice. These results suggest that host factors seem to influence Barrett’s carcinogenesis.
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Background
Gastroesophageal reflux is a significant risk factor for the 
onset of esophageal adenocarcinoma. In Western countries, 
the incidence of gastroesophageal reflux disease (GERD) is 
increasing as a result of a rapid increase in obesity associated 
with high-fat diets [1]. Adenocarcinoma is now accounting 
for over 60% of cases of esophageal cancer overall in the 
USA [2]. Barrett’s epithelium, which indicates the presence 
of columnar metaplasia in the esophagus, has been reported 
to be a precancerous lesion suggestive of esophageal adeno-
carcinoma [3].
We have previously surgically induced the develop-
ment of adenocarcinoma from Barrett’s epithelium in rats 
[4–6]. We have also reported that by providing such reflux 
model animals with a high-fat diet filled with beef tallow, 
the incidence of Barrett’s epithelium increased, resulting 
in a higher incidence of esophageal tumors [5]. Research, 
utilizing genetic information, remains essential in gaining 
a deeper understanding of the onset process of Barrett’s 
epithelium leading to adenocarcinoma. For this purpose, 
mice appear to be more useful than rats, as the genetic back-
ground of mice has been clarified in more detail than that 
of rats. In this study, we examined the histological changes 
in mice reflux modes using additional immunohistochemi-
cal stainings of CDX2, PDX1, and CK7, because CDX2 is 
a homeobox domain-containing transcription factor that is 
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important in the development and differentiation of the intes-
tines and it is widely accepted that CDX2 plays key roles on 
differentiation into the intestinal-type cell characteristic of 
Barrett’s esophagus [7, 8]. PDX1 is reported to be a marker 
of a true Barrett’s epithelium [9]. The expression of CK7 
might help to explain the pathological, reflux-related nature 
of columnar-lined esophagus, as an aberrant expression in 
a very early stage of the multistep Barrett’s esophagus pro-
gression [10]. Recently, Jiang used CK7 as a marker of Bar-
rett’s esophagus [11].
Mouse models have been previously proposed to research 
the onset process of Barrett’s epithelium. Accordingly, the 
present study aimed to establish a duodenal reflux model 
of Barrett’s carcinogenesis using mice. We also need to 
compare the effects of gastroduodenal reflux on esophagus 
between mice and rats. Thus, we utilized the same tech-
niques used in the past to construct rat reflux models on mice 
[5, 8]. However, the onset rates of Barrett’s epithelium and 
adenocarcinoma in mouse models have been extremely low 
compared to rat models [9, 12]. To increase the incidence 
of Barrett’s epithelium and adenocarcinoma in the present 
study, we provided mice with a high-fat diet after performing 
surgery [5] and we also extended the postoperative period 
until killing, compared to the study using rat reflux models. 
However, these treatments did not result in tumor onset from 
Barrett’s epithelium in this study. To verify these results, 
we used taurocholic acid (TCA), which has been reported 
to be actively involved in the onset of Barrett’s epithelium 
and adenocarcinoma, to perform an in vitro investigation of 
cell proliferative activity using human esophagogastric junc-
tion adenocarcinoma cell line (OE19). It has been reported 
that the American prevalences of esophageal adenocarci-
noma and esophagogastric junction adenocarcinoma have 
increased in tandem, because esophagogastric junction 
adenocarcinoma is related to GERD [13]. We also used 
array-based comparative genomic hybridization (CGH) to 
perform a comprehensive analysis of ESCC-DR cells estab-
lished from the intrapleural metastasis focus of squamous 
cell carcinoma that developed in a rat reflux model and 
ESCC-DRtca cells with higher malignant potential induced 
by continuous TCA exposure [14]. In the present study, we 
reinvestigate the effects of bile acid and discuss factors in 
Barrett’s carcinogenesis.
Materials and methods
This study confirmed to the ethical regulations on the use of 
experimental animals, and all experiments were conducted 
based on the animal experiment guidelines of the Research 
Center for Animal Life Science of the Shiga University of 
Medical Science (experiment approval no.: 2016-5-51).
Laboratory animals and the feed
We used 8-week-old male C57BL/6J mice to construct a 
duodenal reflux model and sham surgery group. These mice 
were divided into two groups according to the diet. The feed 
administered was the same as that used in a previous rat 
reflux model [5]. The feed used was a low-fat diet of soybean 
oil derived from soybeans (a standard diet group: CE-2, con-
taining 4.8% soybean oil) and a high-fat diet made of beef 
tallow (a high-fat diet group: Quick Fat, containing 15.3% 
beef tallow). Both were purchased from CLEA Japan, Inc. 
(Osaka, Japan).
Construction of duodenal reflux model and a sham 
surgery group
As a preoperative preparation, the subjects were made to 
fast for 24 h before surgery, only ingesting water. All pro-
cedures were performed with the subjects under inhalation 
anesthesia with isoflurane. The surgical method used was 
almost identical to techniques previously used to construct 
rat duodenal reflux models [5, 8]. First, the E–G junction 
was transected after laparotomy, and the gastric stump was 
closed with continuous sutures using 8-0 nylon (CROWN-
JUN, Chiba, Japan). End-side anastomosis was performed 
between the esophageal cut end and the upper jejunum 
located approximately 2 cm distally from the pylorus ring. 
We added one more serosal suture to the esophagojejunal 
anastomosis (Fig. 1). Physiological saline solution was 
Fig. 1  Mouse reflux model. T Treitz ligament. We performed a gas-
troduodenal contents reflux surgery by esophagojejunostomy without 
gastrectomy. There are anatomical differences in gallbladder between 
rat and mouse. While mice have a gallbladder, rats do not
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injected into the peritoneal cavity to prevent adhesion and 
as postoperative fluid replenishment, and the wound was 
closed. For the construction of the sham surgery group, the 
same pre- and postoperative preparation was implemented 
for the reflux model. Blunt operations, such as gripping 
the organs in the abdominal cavity, were performed after 
laparotomy.
Bile and esophageal tissue collection
At 60 weeks postoperatively, thoracotomy and laparotomy 
were performed under inhalation anesthesia with isoflurane. 
The gallbladder was perforated with a 29-G needle 0.5-mL 
syringe (Terumo Corporation, Tokyo, Japan), and bile was 
suctioned out. The collected bile was stored at − 80 °C 
until analysis. Bile acid analysis was performed by Junshin 
Clinic Bile Acid Institute (Tokyo, Japan). The anastomosed 
upper jejunum and esophagus were collected together. The 
removed samples were fixated with 10% buffered formalin, 
and paraffin blocks were prepared. The paraffin blocks were 
cut into 2-µm slices, and hematoxylin and eosin (HE) stain-
ing was performed for histological investigation.
Immunostaining
The 2-µm slice specimens created from paraffin blocks 
underwent immunostaining with primary antibodies of CK7 
(dilution time is 250:1, cat. #ab9021, Abcam, Tokyo, Japan), 
PDX1 (500:1, cat. #ab9021, Abcam) and CDX2 (250:1, cat. 
#ab76541, Abcam). Histofine MAX-PO (Nichirei, Tokyo, 
Japan), which is specialized for use on mouse tissue, was 
used to activate the antigens with heat treatment, and visu-
alization was then performed using DAB (Nichirei).
Effects of TCA exposure on cell proliferation
The human esophagogastric junction cancer cell line (OE-
19) was purchased from Summit Pharmaceuticals Inter-
national Corporation (Tokyo, Japan). The cells were sub-
cultured in an RPMI 1640 (Nacalai Tesque Co., Kyoto, 
Japan) medium adjusted so that the antibiotic–antimycotic 
solution (Life Technologies Co., CA, USA) and FBS were 
1% and 10%, respectively. OE-19 cells were then seeded 
in a black-walled 96-well plate (Thermo Scientific Nunc; 
Thermo Fisher Scientific, MA, USA) at 1 × 104 cells/well. 
After 24 h, the specimens were washed with D-PBS (Nacalai 
Tesque Co., Kyoto, Japan) and then with modified EPM2 
(AthenaES, MD, USA). Next, specimens were switched 
to a modified EPM2 medium with each concentration of 
TCA (Sigma, MO, USA) and cultured at 37 °C with 5% 
 CO2. The added TCA concentrations were 0, 50, 100, 500, 
and 1000 μM. 48 h after adding the reagent, washing was 
performed twice with D-PBS. Then, D-PBS was added at 
50 μL/well. Then, 4 μM Calcein-AM (Dojindo Laborato-
ries, Kumamoto, Japan) was added to this at 50 μL/well and 
cultured for 1 h at 37 °C. The plate was removed and fluo-
rescence intensity at 515 nm was measured with excitation 
rays at 490 nm.
Array CGH analysis
1. Genetic analysis of esophageal cancer cells developed 
in a rat reflux model
  To identify genes involved in cancer onset in a rat 
reflux model, while we did not have any rat Barrett’s 
adenocarcinoma cell line, we performed comprehensive 
genetic analysis of the ESCC-DR cells with normal rat 
esophageal epithelium as the reference.
2. Genetic analysis of tumor expansion resulting from TCA 
administration
  To identify the genetic abnormalities caused by tumor 
expansion resulting from TCA administration, we per-
formed comprehensive genetic analysis with ESCC-DR 
as the reference and ESCC-DRtca as the test sample.
In both of the above analyses, array CGH analysis was 
performed using Rat Genome CGH Microarray, 4 × 180K 
(Agilent, CA, US). An analysis was performed according to 
the manufacturer’s instructions using DNA Chip Research 
Inc. (Tokyo, Japan). Copy number gains and losses were 
defined as changes in the logarithm to the base 2 of the 
tumor to reference signal intensity ratio (T/R) > 0.3219 
and < −0.3219, respectively.
Statistical analysis
To detect statistically significant differences in the nominal 
variables of the two groups for animal model experimental 
data and bile acid fraction analysis, we used Fisher’s exact 
test. For continuous variables, we used the Mann–Whitney 
U test. Figures were displayed as median values, and a P 
value < 0.05 indicated statistical significance.
Results
Postoperative changes in mouse weight
There were 18 surviving mice in the standard diet group, 
20 surviving mice in the high-fat diet group, and 5 mice 
each in the standard diet and high-fat diet groups that under-
went sham surgery. In the mouse duodenal reflux model, 
the median weight was 27.2 g in the standard diet group 
and 33.2 g in the high-fat diet group, indicating that sub-
jects were significantly heavier in the high-fat diet group (P 
value < 0.05). In the sham surgery group, the median weight 
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was 37.1 g in the CE2 intake group and 48.2 g in the high-fat 
diet group, indicating that subjects were significantly heavier 
in the high-fat diet group (P value < 0.05).
Barrett’s epithelium development
We were able to confirm that Barrett’s epithelium devel-
oped in all subjects in the mouse duodenal reflux model 
near the esophagojejunal anastomosis (Fig. 2a). No marked 
differences of histological results were observed between 
the two groups. All Barrett’s epithelium had intestinal meta-
plasia positive for CDX2 (Fig. 2b). PDX1 is also strongly 
positive for Barrett’s metaplasia (Fig. 2c). There were no 
remarkable differences in the positivity of PDX1 between 
the two groups. Although CK7 was negative for proper jeju-
nal mucosa and squamous epithelium, Barrett’s epithelium 
was positive for CK7 (in the red square of Fig. 2d, e). Some, 
albeit small numbers of, CK7-positive cells were noted at 
sites distant from the anastomotic site in each group (in the 
black square of Fig. 2d, f). While these cells were nega-
tive for CDX2, results suggested these cells are in a very 
early stage of the multistep Barrett’s esophagus progression 
and might be in a stage prior to direct metaplasia in the 
columnar epithelium. These CK7-positive cells seemed to 
be developed from the basal layer of the esophagus-stratified 
squamous epithelium in the regenerative process. Mean-
while, no development of Barrett’s epithelium was noted 
in the sham surgery groups. Moreover, no onset of Barrett’s 
adenocarcinoma was observed in all animals.
Bile acid analysis
A sufficient amount of bile for bile acid fraction analysis was 
suctioned from perforations in the gallbladders in five reflux 
animals in the normal diet group and five reflux animals 
in the high-fat diet group. Of the 107 items investigated in 
detail, we showed the 10 items that were measurable in all 
of the above 10 samples and compared them between the 
two groups (Table 1). T-α-MCA was significantly increased 
in the high-fat intake group (P value = 0.046). No other sig-
nificant differences were noted between the groups for bile 
acid (Table 1).
Effects of bile acid exposure on cell proliferation
TCA administration resulted in increases in cell proliferative 
activity in OE19 in a dose-dependent manner (Fig. 3).
Fig. 2  Immunohistochemical 
stainings of Barrett’s epithe-
lium. a HE staining, b CDX2, 
c PDX1, d CK7, e Higher 
magnification of red square in 
(d). f Higher magnification of 
black square of (d). Black arrow 
and red arrow in (d) indicate 
oral site and the anastomotic 
site, respectively. The Bar-
rett’s epithelium was mostly 
developed near the esophago-
jejunal anastomosis (a, d and 
e). The Barrett’s epithelium 
strongly expressed CDX2 in (b), 
PDX2 in (c), and CK7 in the red 
square of (d, e). Small numbers 
of CK7-positive cells were 
noted at sites distant from the 
anastomotic site in each group 
in the black square of (d, f)
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Genetic abnormalities in ESCC‑DR
Of the genes, such as UGT2B, that were amplified by 
array CGH analysis of ESCC-DR, the ten with the highest 
amplification rates were ranked in order (only genes for 
which the gene name has been clarified) and are shown 
in Table 2.
Table 1  Bile acid composition (mmol/L) of bile juice aspirated from 
gallbladder of the reflux models in each group
Values are expressed as median
H high-fat group fed a high cow-fat diet (Quick Fat), S standard diet 
group fed a soybean oil diet (CE-2)
*Significant difference, P < 0.05
60 W (reflux models)
S (mmol/L) H (mmol/L) p value























Total bile acids (TBA) 98.7 100.6 0.548
Fig. 3  The effects of TCA administration on cell proliferation in 
OE19 cells. TCA promotes cell proliferation in a dose-dependent 
manner
Table 2  Up-regulated genes in ESCC-DR obtained by arrayCGH 
analysis
UCSC position/search Name of gene Ratio
1 chr9: 110301814–110301873 MYOM1 6.22
2 chr10: 87353525–87353584 IKZF3 5.98
3 chr3: 22733900–22733959 LRP1B 5.86
4 chr17: 14874142–14874201 CATSPER3 5.55
5 chr6: 101948867–101948926 RDH11 5.40
6 chr3: 47830793–47830852 CSRNP3 5.32
7 chr14: 22158617–22158676 UGT2B 4.70
8 chr2: 21149053–21149112 ATG10 4.69
9 chr2: 191559460–191559519 RNF115 4.05
10 chr9: 71822103–71822162 SMARCAL1 3.98
Fig. 4  Comparison of ESCC-DR and ESCC-DRtca by array CGH. 
Gains and losses are indicated with red and green, respectively. We 
performed comprehensive genetic analysis with ESCC-DR as the 
control and ESCC-DRtca as the test sample. Many chromosomal 
abnormalities were detected
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Comparison of ESCC‑DR and ESCC‑DRtca
Comparison of ESCC-DR and ESCC-DRtca revealed 
that when tumor expansion resulted from TCA admin-
istration, many chromosomal abnormalities developed 
(Fig. 4).
Discussion
In the mouse reflux model, cancer onset from Barrett’s 
epithelium was not observed even when a high-fat diet was 
administered. We were only able to confirm Barrett’s epi-
thelium near the anastomotic site. The Barrett’s epithelium 
was positive for PDX-1 in this study. It has been reported 
that PDX-1 is usually expressed in the gastric antrum, 
duodenum, and pancreas, and is absent in the esophagus, 
gastric fundus, and jejunum. On the other hand, PDX-1 is 
initially negative in the jejunum. Gastric intestinal meta-
plasia was reported to be positive for PDX-1, suggesting 
duodenal metaplasia rather than general intestinal meta-
plasia [15]. Furthermore, we did not observe any columnar 
epithelium metaplasia located extensively throughout the 
proximal side of the esophagus and far from the anasto-
motic site as was the case for a rat reflux model [16].
The fact that Barrett’s adenocarcinoma onset rates and 
histogenesis of Barrett’s epithelium differ between mice 
and rats despite undergoing similar reflux stimulation may 
have been due to the following two reasons: First, it could 
have been due to anatomical differences between rat and 
mouse gallbladders. In rat reflux models without a gall-
bladder, bile reflux occurs continuously into the esopha-
gus together with duodenal fluid. However, in a mouse 
reflux model with a gallbladder, there appears to be no 
continuous bile reflux into the esophagus even if the upper 
jejunum is surgically anastomosed to the esophagus. In 
human cases, it has been reported that esophageal adeno-
carcinoma incidence increases after gallbladder extraction 
[17]. This suggests that the presence of the gallbladder 
may affect the onset of adenocarcinoma. The second pos-
sible reason is that bile acid constitution and bile acid may 
have different effects on esophageal tissue in rats and mice. 
Human bile acid is said to contain a large proportion of 
glycine-conjugated bile acid with glycine conjugates-to-
taurine conjugates constitution at 3:1 [18]. Nehra et al. 
have reported that in cases that exhibit Barrett’s epithe-
lium and esophagitis onset, taurine conjugates are domi-
nant in the esophagus [19]. We previously reported that an 
increased proportion of taurine conjugates, due to a high-
fat diet, affected Barrett’s epithelium formation and atypi-
cal epithelium onset rates in the rat reflux model [5], and 
chronic exposure to TCA caused tumor progression [14]. 
Accordingly, in our study, we performed an additional 
in vitro experiment to confirm how TCA affects tumor pro-
gression. Research using esophagogastric junction adeno-
carcinoma cell line (OE-19) has indicated that TCA causes 
more increases in cell proliferative activity. In vitro, the 
other experiments also indicated that taurine-conjugated 
bile acids activate Src, EGFR, and ERK, thereby caus-
ing colorectal cancer cells to proliferate [20]. The present 
study also showed that more chromosomal abnormalities 
developed in ESCC-DRtca than ESCC-DR. In this study, 
bile acid fraction analysis of mouse gallbladder bile indi-
cated that most were taurine conjugates, and the admin-
istration of a high-fat diet led to significant increases in 
T-α-MCA. However, Barrett’s epithelium only developed 
near the esophagus–jejunum anastomotic site, and no cases 
of adenocarcinoma were noted. Terabe et al. performed 
esophagogastrojejunostomy (side-to-side) without total 
gastrectomy [9]. They reported that these model developed 
metaplasia and dysplasia more frequently than the model 
of esophageal separation and esophagojejunostomy (end-
to-side) similar to our model in the present study [9]. The 
model may be superior to our reflux model on the point 
of inducing both gastric acid and bile acid reflux to occur. 
For a mice model in the future, we might use the model of 
esophagogastrojejunostomy. However, even in this model 
no adenocarcinoma developed in the previous study [9]. 
These findings suggest that host factors may influence Bar-
rett’s carcinogenesis.
As one of the host factors affected in Barrett’s carcino-
genesis, we focused on the fact that UGT2B amplification 
was noted in the analysis of genetic abnormalities in the 
ESCC-DR cell line. Bile acid is an essential substrate for 
UGT2B, and one can easily see that UGT2B is involved in 
cancer onset in reflux models with significant exposure to 
bile acid. It has been confirmed that UGT is present in not 
only the liver, but also the small intestine, kidneys, brain, 
and esophagus [21, 22]. UGT2B is present in esophageal 
squamous cell carcinoma, with some recent reports indicat-
ing that it is related to prostate cancer and UGT2B genetic 
polymorphisms [23, 24]. Accordingly, genetic polymor-
phisms between UGT2B specimens might also be actively 
involved in the metabolism of carcinogens in the digestive 
tract. We previously reported that endogenous nitrosated bile 
acid conjugates derived from duodenal content reflux have 
mutagenicity and the N-nitroso bile acid is actively involved 
in Barrett’s carcinogenesis [25–27]. Although we did not 
compare the UGT2B polymorphisms between rats and mice, 
it might be that UGT expression in the esophagus and small 
intestine differs between mice and rats. This suggests that 
the detoxification of nitroso compounds produced from bile 
and gastric acid and the metabolism of other carcinogens 
may also differ between rats and mice. An epidemiologi-
cal study on humans found that Barrett’s adenocarcinoma 
incidence has been rapidly increasing mainly among white 
270 Esophagus (2019) 16:264–271
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men, demonstrating clear racial- and gender-related differ-
ences in the incidence of Barrett’s adenocarcinoma [28]. 
These findings suggest that the effects of bile acid and other 
carcinogens on esophageal mucosa may differ depending on 
host factors such as UGT2B genetic polymorphisms.
We understand that there is a limitation in the present 
study. It is very challenging to say something about Bar-
rett’s carcinogenesis from the present results based on 
a mice model, because we failed to establish the mouse 
model for inducing Barrett’s adenocarcinoma. We found 
that most of the mouse bile acid was taurine conjugates, 
and we confirmed the effects of TCA in cancer progres-
sion in vitro using OE-19, ESCC-DR, and ESCC-DRtca. 
If we had obtained mice Barrett’s adenocarcinoma cells, 
we might have shown the validity of adapting the data of 
CGH and genetic polymorphism on rat squamous cell line 
to mouse Barrett’s carcinogenesis more clearly. However, 
we can say that Barrett’s adenocarcinoma onset rates dif-
fer between mice and rats despite undergoing similar reflux 
stimulation, and that host factors seem to influence Barrett’s 
carcinogenesis. Although we had continued to use rat reflux 
models to perform research focusing on risk factors for Bar-
rett’s carcinogenesis until now, host factor effects also need 
to be taken into consideration in the future. One factor for 
this appears to be the presence of the UGT-2B gene and 
its genetic polymorphisms, which may be involved in host 
physiological reactions to bile acid irritation.
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